Loading…
Loading…
Abbvie Inc
NYSE · Stock Profile · Market Cap $388.40B
Current Price
$208.30
-5.21%GoodMoat Value
$182.41
12.4% overvaluedEarnings per share grew at a 43.6% CAGR.
Forward estimates use 43.6% FCF growth (CAGR)
Net Debt: 62.3B
14.5B
FY24
14.5B
FY24
56.3B
FY24
13.3B
FY25
15.4B
FY25
15.8B
FY25
61.2B
FY25
1.4B
FY24
1.6B
FY24
4.3B
FY24
1.3B
FY25
938M
FY25
186M
FY25
4.2B
FY25
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio.
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Country
Illinois, USA
Earnings per share grew at a 43.6% CAGR.
Blended fair value estimate based on DCF, Graham Number, and earnings-based models.
Run a full DCF analysis with customizable assumptions
Open DCF Calculator →Graham Number, PEG-based, and Earnings-based models
View Fair Value →Dividend Yield
3.16%
AbbVie's mission is to discover and deliver innovative medicines and solutions that solve serious health issues today and address the medical challenges of tomorrow. We strive to have a remarkable impact on people's lives across several key therapeutic areas including immunology, neuroscience and oncology – and products and services in our Allergan Aesthetics portfolio.
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
NYSE
Country
Illinois, USA